These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy. Soares MB; de Lima RS; Rocha LL; Vasconcelos JF; Rogatto SR; dos Santos RR; Iacobas S; Goldenberg RC; Iacobas DA; Tanowitz HB; de Carvalho AC; Spray DC J Infect Dis; 2010 Aug; 202(3):416-26. PubMed ID: 20565256 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes. Navarro IC; Ferreira FM; Nakaya HI; Baron MA; Vilar-Pereira G; Pereira IR; Silva AM; Real JM; De Brito T; Chevillard C; Lannes-Vieira J; Kalil J; Cunha-Neto E; Ferreira LR PLoS Negl Trop Dis; 2015; 9(6):e0003828. PubMed ID: 26086673 [TBL] [Abstract][Full Text] [Related]
11. Functional genomic fabrics are remodeled in a mouse model of Chagasic cardiomyopathy and restored following cell therapy. Iacobas DA; Iacobas S; Tanowitz HB; Campos de Carvalho A; Spray DC Microbes Infect; 2018 Mar; 20(3):185-195. PubMed ID: 29158000 [TBL] [Abstract][Full Text] [Related]
12. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J Front Immunol; 2020; 11():306. PubMed ID: 32194558 [TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effects of phosphoramidon on myocardial structure and function in murine Chagas' disease. Jelicks LA; Chandra M; Shirani J; Shtutin V; Tang B; Christ GJ; Factor SM; Wittner M; Huang H; Weiss LM; Mukherjee S; Bouzahzah B; Petkova SB; Teixeira MM; Douglas SA; Loredo ML; D'Orleans-Juste P; Tanowitz HB Int J Parasitol; 2002 Nov; 32(12):1497-506. PubMed ID: 12392915 [TBL] [Abstract][Full Text] [Related]
14. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs. Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285 [TBL] [Abstract][Full Text] [Related]
15. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E Hernández M; Wicz S; Corral RS Phytomedicine; 2016 Nov; 23(12):1392-1400. PubMed ID: 27765359 [TBL] [Abstract][Full Text] [Related]
16. Phosphoramidon treatment improves the consequences of chagasic heart disease in mice. Jelicks LA; Chandra M; Shtutin V; Petkova SB; Tang B; Christ GJ; Factor SM; Wittner M; Huang H; Douglas SA; Weiss LM; Orleans-Juste PD; Shirani J; Tanowitz HB Clin Sci (Lond); 2002 Aug; 103 Suppl 48():267S-271S. PubMed ID: 12193101 [TBL] [Abstract][Full Text] [Related]
17. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Garg N; Popov VL; Papaconstantinou J Biochim Biophys Acta; 2003 Jul; 1638(2):106-20. PubMed ID: 12853116 [TBL] [Abstract][Full Text] [Related]
18. Chagasic cardiomyopathy, from acute to chronic: is this mediated by host susceptibility factors? Henao-Martínez AF; Schwartz DA; Yang IV Trans R Soc Trop Med Hyg; 2012 Sep; 106(9):521-7. PubMed ID: 22819769 [TBL] [Abstract][Full Text] [Related]
19. Canonical PI3Kγ signaling in myeloid cells restricts Trypanosoma cruzi infection and dampens chagasic myocarditis. Silva MC; Davoli-Ferreira M; Medina TS; Sesti-Costa R; Silva GK; Lopes CD; Cardozo LE; Gava FN; Lyroni K; Dias FC; Frade AF; Baron M; Nakaya HI; Figueiredo F; Alves-Filho JC; Cunha FQ; Tsatsanis C; Chevillard C; Cunha-Neto E; Hirsch E; Silva JS; Cunha TM Nat Commun; 2018 Apr; 9(1):1513. PubMed ID: 29666415 [TBL] [Abstract][Full Text] [Related]